Octava Minerals Limited (OCT.AX)
AUD 0.13
(0.0%)
AUD 0.13
(0.0%)
| Breakdown | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
| Revenue | 200 Thousand | 400 Thousand | - | - |
| Cost of Revenue | - | - | - | - |
| Gross Profit | 200 Thousand | 400 Thousand | - | - |
| Operating Expenses | 899.4 Thousand | 874.2 Thousand | 1.01 Million | 316.92 Thousand |
| Selling, General and Administrative Expenses | 967.83 Thousand | 874.2 Thousand | 1.01 Million | 316.92 Thousand |
| Research and Development Expenses | - | - | - | - |
| Other Expenses | -68.43 Thousand | 115.5 Thousand | - | - |
| Cost and Expenses | 899.4 Thousand | 874.2 Thousand | 1.01 Million | 316.92 Thousand |
| Operating Income | -899.4 Thousand | -874.2 Thousand | -1.01 Million | -316.93 Thousand |
| Interest Expense | - | 186.00 | - | - |
| Income Tax Expense | - | -15.25 Thousand | -226.82 Thousand | -236.55 Thousand |
| Earnings before Tax | -797.64 Thousand | -752.72 Thousand | -1.52 Million | -522.2 Thousand |
| Net Income | -797.64 Thousand | -752.72 Thousand | -1.52 Million | -522.2 Thousand |
| Earnings Per Share Basic | -0.02 | -0.02 | -0.03 | -0.01 |
| Earnings Per Share Diluted | -0.02 | -0.02 | -0.03 | -0.01 |
| Weighted Average Shares Outstanding | 47.11 Million | 38.99 Million | 46.14 Million | 46.14 Million |
| Weighted Average Shares Outstanding (Diluted) | 47.11 Million | 38.99 Million | 46.14 Million | 46.14 Million |
| Gross Margin | 1.00 | 1.00 | - | - |
| EBIT Margin | -3.99 | -2.07 | - | - |
| Profit Margin | -3.99 | -1.88 | - | - |
| EBITDA | -797.64 Thousand | -752.72 Thousand | -790.28 Thousand | -316.93 Thousand |
| Earnings Before Tax Margin | -4.50 | -2.19 | - | - |
| Breakdown | 2024 Q4 | 2024 Q2 | 2023 FY | 2023 Q4 | 2023 Q2 | 2022 Q4 |
|---|---|---|---|---|---|---|
| Revenue | -58.83 Thousand | 58.83 Thousand | 400 Thousand | -8508.00 | 8508.00 | -36.00 |
| Cost of Revenue | - | - | - | - | - | - |
| Gross Profit | -58.83 Thousand | 58.83 Thousand | 400 Thousand | -8508.00 | 8508.00 | -36.00 |
| Operating Expenses | 840.56 Thousand | 589.08 Thousand | 874.2 Thousand | 456.5 Thousand | 382.01 Thousand | 249.52 Thousand |
| Selling, General and Administrative Expenses | 442.13 Thousand | 525.7 Thousand | - | 456.5 Thousand | 382.01 Thousand | 249.52 Thousand |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | 398.43 Thousand | - | 115.5 Thousand | - | - | - |
| Cost and Expenses | 840.56 Thousand | 589.08 Thousand | 874.2 Thousand | 456.5 Thousand | 382.01 Thousand | 249.52 Thousand |
| Operating Income | -899.4 Thousand | -523.25 Thousand | -874.2 Thousand | -456.5 Thousand | -382.01 Thousand | -249.52 Thousand |
| Interest Expense | - | - | 186.00 | - | - | - |
| Income Tax Expense | 445.42 Thousand | -56.38 Thousand | -15.25 Thousand | -59.44 Thousand | -373.5 Thousand | 385.38 Thousand |
| Earnings before Tax | -267.38 Thousand | -530.25 Thousand | -752.72 Thousand | -343.53 Thousand | -409.19 Thousand | -451.74 Thousand |
| Net Income | -267.38 Thousand | -530.25 Thousand | -752.72 Thousand | -343.53 Thousand | -409.19 Thousand | -451.74 Thousand |
| Earnings Per Share Basic | -0.01 | -0.01 | - | -0.01 | -0.01 | -0.01 |
| Earnings Per Share Diluted | -0.01 | -0.01 | - | -0.01 | -0.01 | -0.01 |
| Weighted Average Shares Outstanding | 47.2 Million | 46.83 Million | 38.99 Million | 46.14 Million | 46.14 Million | 46.14 Million |
| Weighted Average Shares Outstanding (Diluted) | 47.39 Million | 46.83 Million | 38.99 Million | 46.14 Million | 46.14 Million | 46.14 Million |
| Gross Margin | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| EBIT Margin | 8.51 | -7.94 | - | 97.49 | -44.90 | 6931.11 |
| Profit Margin | 4.54 | -9.01 | -1.88 | 40.38 | -48.09 | 12.54 Thousand |
| EBITDA | -500.97 Thousand | -466.86 Thousand | - | -829.45 Thousand | -382.01 Thousand | -249.52 Thousand |
| Earnings Before Tax Margin | 15.29 | -8.89 | -2.19 | 53.66 | -44.90 | 6931.11 |
LODHA
CME
AMBUJACEM
6272
9744
PFIZER